← All trials
NCT04460586
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2020
- Primary completion
- Dec 1, 2021
- Completion date
- Dec 31, 2021
- First posted
- Jul 7, 2020
- Last posted
- Jul 8, 2020
- Enrollment
- 12
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of Southern CaliforniaLead sponsor
- University of Southern CaliforniaSponsor investigator
- Paratek Pharmaceuticals IncCollaborator
- University of Southern CaliforniaStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.